Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Communications    tags : Trial    save search
Citius Pharmaceuticals Announces Addition of City of Hope to UMN's Phase 1 Trial of LYMPHIR in Combination with CAR-T for the Treatment of B-Cell Lymphoma
Published: 2024-04-11 (Crawled : 20:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | | O: -100.0% H: NaN% C: Infinity%
GILD | $67.03 0.12% 0.12% 5.2M twitter stocktwits trandingview |
Health Technology
 | | O: 0.5% H: 0.83% C: 0.28%
CTXR | $0.772 5.15% 4.9% 670K twitter stocktwits trandingview |
Health Technology
 | | O: 2.33% H: 2.28% C: -4.23%
hope treatment pharmaceuticals city for car-t trial
GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | | O: 0.17% H: 0.0% C: -0.43%
gammatile tumors for trial
Merck Provides Update on Phase 3 KEYLYNK-006 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Maintenance LYNPARZA® (olaparib) for Certain Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer
Published: 2024-03-21 (Crawled : 12:00) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.13% H: 0.4% C: -0.06%
ylynk-006 keytruda lung merck update cancer cell trial plus
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
Published: 2024-03-07 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | | O: 0.79% H: 0.78% C: 0.78%
MBIO | $0.3355 -1.32% -1.34% 120K twitter stocktwits trandingview |
Health Technology
 | | O: 8.33% H: 4.2% C: -2.8%
FBIO | $1.79 2.29% 2.23% 190K twitter stocktwits trandingview |
Health Technology
 | | O: 2.93% H: 0.0% C: -9.21%
tumors cell city trial therapy
City of Hope presents pivotal clinical trial data at American Society of Hematology (ASH) conference on revumenib, a potential new targeted therapy for high-risk subtypes of acute leukemias
Published: 2023-12-12 (Crawled : 21:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | | O: -0.07% H: 1.35% C: -0.1%
conference hope city trial potential therapy
Merck Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® (olaparib) for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
MRK | $126.88 -0.05% -0.13% 7.5M twitter stocktwits trandingview |
Health Technology
 | | O: -0.04% H: 0.01% C: -1.61%
ylynk-008 keytruda lung merck cancer cell trial plus
Nokia and Orange set record with 800Gbps transmission trial on 6,600km Dunant live network to prepare for soaring traffic on strategic trans-Atlantic route
Published: 2023-12-06 (Crawled : 08:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
set network trial
BioXcel Therapeutics Aligns with FDA Recommendation for Phase 3 Trial for TRANQUILITY Program, Provides Update on Strategic Financing, and Reports Third Quarter 2023 Financial Results
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
BTAI | News | $2.965 4.04% 3.88% 410K twitter stocktwits trandingview |
Health Technology
 | | O: -35.39% H: 19.38% C: 18.54%
fda update trial therapeutics financial results
ROSEN, TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Published: 2023-11-11 (Crawled : 00:20) - prnewswire.com
LUMN | $1.36 1.47% 8.7M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
SCYX | $1.53 6.25% 5.88% 150K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
DCGO | $3.505 -0.14% -0.14% 570K twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DocGo Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - DCGO
Published: 2023-11-11 (Crawled : 00:20) - prnewswire.com
LUMN | $1.36 1.47% 8.7M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
SCYX | $1.53 6.25% 5.88% 150K twitter stocktwits trandingview |
Health Technology
 | Email alert Add to watchlist
DCGO | $3.505 -0.14% -0.14% 570K twitter stocktwits trandingview |
| Email alert Add to watchlist
deadline trial
ROSEN, NATIONAL TRIAL LAWYERS, Encourages PureCycle Technologies, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - PCT, PCTTW, PCTTU
Published: 2023-10-20 (Crawled : 22:00) - prnewswire.com
LUMN | $1.36 1.47% 8.7M twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
NKLA | News | $0.6323 0.29% 0.28% 47M twitter stocktwits trandingview |
Consumer Durables
 | Email alert Add to watchlist
deadline trial
Viking Therapeutics to Highlight Data from Phase 1 Clinical Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Oral Presentation at ObesityWeek 2023
Published: 2023-10-10 (Crawled : 20:00) - prnewswire.com
VKTX | $64.99 1.79% 1.75% 2M twitter stocktwits trandingview |
Health Technology
 | | O: 1.32% H: 1.48% C: -5.13%
LGND | $69.97 2.1% 2.06% 140K twitter stocktwits trandingview |
Health Technology
 | | O: -0.58% H: 0.0% C: -1.88%
vk2735 obesityweek agonist presentation trial therapeutics
Inland Empire Trial Lawyer William D. Shapiro Elected National Vice President of the American Board of Trial Advocates (ABOTA)
Published: 2023-10-06 (Crawled : 20:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
trial
City of Hope Opens First U.S. Multicenter Clinical Trial for Robotic Single-Port Mastectomies for Breast Cancer Patients
Published: 2023-10-03 (Crawled : 16:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
breast hope cancer city trial
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Verizon Communications Inc. Investors with Losses to Secure Counsel Before Important October 2 Deadline in Securities Class Action Filed by the Firm - VZ
Published: 2023-09-18 (Crawled : 20:00) - prnewswire.com
VZ | News | $39.7 2.85% 0.0% 24M twitter stocktwits trandingview |
Communications
 | | O: -0.81% H: 0.0% C: 0.0%
SYNH | $42.98 0.0% 7.4M twitter stocktwits trandingview |
Health Services
 | | O: 0.02% H: 0.14% C: 0.09%
deadline communications trial
TIGR FINAL DEADLINE TOMORROW: ROSEN, LEADING TRIAL ATTORNEYS, Encourages UP Fintech Holding Limited Investors to Secure Counsel Before Important August 21 Deadline in Securities Class Action Filed by the Firm - TIGR
Published: 2023-08-20 (Crawled : 20:20) - prnewswire.com
VZ | News | $39.7 2.85% 0.0% 24M twitter stocktwits trandingview |
Communications
 | | O: 0.38% H: 0.0% C: 0.0%
TIGR | $3.375 5.14% 4.89% 1M twitter stocktwits trandingview |
Finance
 | | O: -2.4% H: 4.6% C: 3.68%
INFI | $0.016 12.5% 1.1M twitter stocktwits trandingview |
Health Technology
 | | O: 0.0% H: 0.0% C: 0.0%
deadline trial
Calidi Biotherapeutics and City of Hope Announce First Patient Dosed in a Phase 1 Clinical Trial Evaluating Neural Stem Cells Engineered to Carry an Oncolytic Virus, CLD-101, in Recurrent High-grade Glioma Patients
Published: 2023-07-18 (Crawled : 14:00) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
cld-101 hope city trial
Lyndra Therapeutics Announces Leadership Changes, Update on Pivotal Trial Progress
Published: 2023-07-17 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
 | | O: 4.62% H: 0.0% C: -1.54%
GILD | $67.03 0.12% 0.12% 5.2M twitter stocktwits trandingview |
Health Technology
 | | O: -0.67% H: 1.42% C: 1.06%
update trial therapeutics
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-26 (Crawled : 21:00) - prnewswire.com
LLY | News | $745.69 1.96% -0.16% 2M twitter stocktwits trandingview |
Health Technology
 | | O: 2.15% H: 1.18% C: 0.43%
SRNE | $0.015 -8.85% 140K twitter stocktwits trandingview |
Health Technology
 | | O: -1.0% H: 4.2% C: 1.3%
SGEN | $228.74 0.1% 20M twitter stocktwits trandingview |
Health Technology
 | | O: 0.82% H: 0.02% C: -0.85%
SNY | News | $47.69 1.15% 1.13% 1.7M twitter stocktwits trandingview |
Health Technology
 | | O: 0.17% H: 0.0% C: 0.0%
OMER | $3.08 0.0% 210K twitter stocktwits trandingview |
Health Technology
 | | O: 0.19% H: 2.22% C: 1.76%
IMGN | News | $31.23 0.03% 49M twitter stocktwits trandingview |
Health Technology
 | | O: 0.58% H: 2.57% C: 0.26%
companies pipeline trial
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Telephone and Data Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TDS, TDSPrU, TDSPrV
Published: 2023-05-20 (Crawled : 00:20) - prnewswire.com
TDS | $15.71 0.9% -1.85% 710K twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
VTNR 4 | $1.675 8.07% 7.46% 3.1M twitter stocktwits trandingview |
Industrial Services
 | Email alert Add to watchlist
USM | $35.77 2.32% 0.0% 140K twitter stocktwits trandingview |
Communications
 | Email alert Add to watchlist
deadline trial
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance
EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance
SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.